Securities code: 000756 securities abbreviation: Shandong Xinhua Pharmaceutical Company Limited(000756) Announcement No.: 2021-72 Shandong Xinhua Pharmaceutical Company Limited(000756)
Announcement on the reply (Revised Version) to the feedback on the application documents for non-public offering of a shares
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions.
On July 30, 2021, Shandong Xinhua Pharmaceutical Company Limited(000756) (hereinafter referred to as “the company”) has received the notice on the first feedback of the CSRC on the examination of administrative licensing projects (No. 211868) (hereinafter referred to as “the feedback notice”) issued by the China Securities Regulatory Commission (hereinafter referred to as “the CSRC”). According to the requirements of the feedback notice, the company will cooperate with relevant intermediaries to The problems listed in the notice of feedback have been carefully studied and answered one by one, and the feedback has been replied and publicly disclosed. For details, see the release on cninfo.com on August 17, 2021（ http://www.cn.info.com..cn. ）Reply to the feedback on Shandong Xinhua Pharmaceutical Company Limited(000756) non-public Development Bank A-share application documents (hereinafter referred to as “feedback reply”).
According to the further review opinions of China Securities Regulatory Commission, the company, together with relevant intermediaries, supplemented and revised the contents of the reply to feedback opinions. See the details published on cninfo.com on the same day（ http://www.cn.info.com..cn. ）Reply to the feedback on Shandong Xinhua Pharmaceutical Company Limited(000756) non-public Development Bank A-share application documents (Revised Version). The company will timely submit the relevant materials of the feedback to the CSRC in accordance with the relevant requirements.
The company’s non-public offering of A-Shares needs to be approved by the CSRC. The company will timely disclose relevant information according to the progress of relevant matters, and investors are kindly requested to pay attention to investment risks.
It is hereby announced.
Shandong Xinhua Pharmaceutical Company Limited(000756) December 22, 2021
